ATE168102T1 - 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren - Google Patents

1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren

Info

Publication number
ATE168102T1
ATE168102T1 AT94902658T AT94902658T ATE168102T1 AT E168102 T1 ATE168102 T1 AT E168102T1 AT 94902658 T AT94902658 T AT 94902658T AT 94902658 T AT94902658 T AT 94902658T AT E168102 T1 ATE168102 T1 AT E168102T1
Authority
AT
Austria
Prior art keywords
4alkyl
pct
optionally substituted
halogen
phenyl
Prior art date
Application number
AT94902658T
Other languages
English (en)
Inventor
Duncan Robert Armour
Philip Charles Box
Pritom Shah
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE168102T1 publication Critical patent/ATE168102T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94902658T 1992-12-05 1993-12-02 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren ATE168102T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929225492A GB9225492D0 (en) 1992-12-05 1992-12-05 Amine derivatives

Publications (1)

Publication Number Publication Date
ATE168102T1 true ATE168102T1 (de) 1998-07-15

Family

ID=10726205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94902658T ATE168102T1 (de) 1992-12-05 1993-12-02 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren

Country Status (29)

Country Link
US (1) US5569654A (de)
EP (1) EP0672037B1 (de)
JP (1) JPH08504200A (de)
KR (1) KR950704270A (de)
CN (1) CN1093085A (de)
AT (1) ATE168102T1 (de)
AU (1) AU688295B2 (de)
BG (1) BG99696A (de)
BR (1) BR9307580A (de)
CA (1) CA2150461A1 (de)
CZ (1) CZ138495A3 (de)
DE (1) DE69319614D1 (de)
EC (1) ECSP941085A (de)
FI (1) FI952709A (de)
GB (1) GB9225492D0 (de)
HU (1) HUT71339A (de)
IL (1) IL107869A (de)
MX (1) MX9307654A (de)
NO (1) NO952208L (de)
NZ (1) NZ258874A (de)
OA (1) OA10161A (de)
PE (1) PE54294A1 (de)
PL (1) PL309281A1 (de)
RO (1) RO114446B1 (de)
RU (1) RU95114528A (de)
SK (1) SK74195A3 (de)
TW (1) TW237450B (de)
WO (1) WO1994013648A1 (de)
ZA (1) ZA939068B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
US5428157A (en) * 1993-11-22 1995-06-27 Merck & Co., Inc. 3-acylaminobenzodiazepines
AU2446295A (en) * 1994-04-15 1995-11-10 Glaxo Inc. A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
US5807876A (en) * 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
AUPO284396A0 (en) * 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
AU6896298A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
AU6896398A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
JP2002513412A (ja) 1997-04-14 2002-05-08 シーオーアール セラピューティクス インコーポレイテッド 選択的Xa因子阻害剤
US6333321B1 (en) * 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6100254A (en) * 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
IL158959A (en) * 2001-05-25 2010-06-30 Cephalon Inc Solid pharmaceutical formulations comprising modafinil
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
CA2589274A1 (en) * 2004-12-07 2006-06-15 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
CA2589271A1 (en) * 2004-12-07 2006-06-15 Locus Pharmaceuticals, Inc. Urea inhibitors of map kinases
WO2007081690A2 (en) * 2006-01-04 2007-07-19 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032226A1 (en) * 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepine analogs
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents

Also Published As

Publication number Publication date
AU688295B2 (en) 1998-03-12
JPH08504200A (ja) 1996-05-07
EP0672037B1 (de) 1998-07-08
BR9307580A (pt) 1999-06-29
RO114446B1 (ro) 1999-04-30
DE69319614D1 (de) 1998-08-13
ZA939068B (en) 1994-08-09
HU9501622D0 (en) 1995-08-28
NZ258874A (en) 1996-09-25
OA10161A (en) 1996-12-18
HUT71339A (en) 1995-11-28
NO952208D0 (no) 1995-06-02
CZ138495A3 (en) 1995-12-13
FI952709A (fi) 1995-08-01
TW237450B (de) 1995-01-01
AU5694894A (en) 1994-07-04
ECSP941085A (es) 1994-12-15
EP0672037A1 (de) 1995-09-20
WO1994013648A1 (en) 1994-06-23
PE54294A1 (es) 1995-01-06
IL107869A (en) 1998-10-30
CN1093085A (zh) 1994-10-05
IL107869A0 (en) 1994-04-12
FI952709A0 (fi) 1995-06-02
BG99696A (bg) 1996-01-31
RU95114528A (ru) 1997-06-10
PL309281A1 (en) 1995-10-02
CA2150461A1 (en) 1994-06-23
MX9307654A (es) 1994-06-30
US5569654A (en) 1996-10-29
SK74195A3 (en) 1995-11-08
GB9225492D0 (en) 1993-01-27
KR950704270A (ko) 1995-11-17
NO952208L (no) 1995-08-02

Similar Documents

Publication Publication Date Title
ATE168102T1 (de) 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren
CO4970780A1 (es) Nuevos compuestos heterociclicos de piridazina
NZ336302A (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
NZ503076A (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives and addition salts thereof, with antagonism against amino acid receptors (particularly AMPA receptor) and processes for their preparation
ATE156804T1 (de) Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
BG97221A (bg) Ортозаместени бифениламидини и бифенилизанидини и съдържащите ги антидиабетични или хипогликемични средства
DK0759027T3 (da) Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase
ATE168672T1 (de) Indol-piperazin-derivate als selektive liganden der 5ht1d und 5ht1b receptoren verwendbar als arzneimittel
DK0678090T3 (da) Piperazinderivater
ATE233242T1 (de) Chinoline und chinazoline verbindungen und ihre therapeutische anwendung
ATE199543T1 (de) Bibphenylamid-derivate als 5-ht1d-antagonisten
CO5540322A2 (es) Nuevos derivados heterociclicos que comprenden un anillo de tetrahidroisoquinolina y uso farmaceutico de los mismos
ATE152442T1 (de) Substituierte arylalkylaminobenzyl- aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
DK1220848T3 (da) N-arylmethylthioanilid-forbindelser, som er nyttige til inhibition af replikationen af HIV
ATE172454T1 (de) Pyridazinon derivate mit pharmazeutischer wirkung
ATE259359T1 (de) Benzoxazol-derivate zur verwendung als integrin- inhibitoren
ATE191465T1 (de) Carbamoylcarbonsäureamide
NZ337749A (en) Benzimidazole derivative and their use in allergy-related disease
DE69627346D1 (de) 4-aryl-thio-pyridin-2(1h)-onen, diese enthaltende arzneimittel und ihre anwendungen bei der behandlung von mit hiv zusammenhängenden krankheiten
ES2010089A6 (es) Procedimiento para la obtencion de n-oxidos de gamma-carbolina antipsicoticos.
TH15971A (th) อนุพันธ์ของแอมีน
BG96022A (bg) 2-(2'метил-3',4'-тризаместени бензол)-1,3- циклохександиони, метод за борба срещу нежелана растителност и хербициден състав, използващ тези съединения
ES2120885A1 (es) Nuevas tienopirimidonas con actividad antifungica.
ECSP920822A (es) Composiciones heterocyclicas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties